Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq?

Vertex Pharmaceuticals Incorporated (VRTX), based in Boston, Massachusetts, is a prominent biotech firm specializing in the discovery, development, and commercialization of innovative small-molecule drugs targeting serious diseases. Its core focus includes genetic disorders such as cystic fibrosis (CF) and sickle cell disease. The company operates globally with extensive R&D and commercial sites, driving advancements through substantial investment in research, a strong manufacturing base, and efficient wo ...